Top-level skin cancer research acknowledging the individuality of cancer is conducted in Turku. In the studies, the characteristics of cancer are examined at the level of tracers and molecules. This opens up the opportunity to tailor the most suitable treatment for each patient. The studies are rewarding for both the researchers and the research subjects. At best, patients with advanced skin cancer benefit from the new medicinal products used in trials long before these products are in commercial use.
The question of sleep apnea as the risk factor for COVID-19 arose in a study conducted by the Turku University Hospital and the University of Turku on patients of the first wave of the pandemic. This is the first COVID-19-related study where sleep apnea as suspected risk factor emerges as the main finding.
The main task of the discipline is to give medical students the basic education in pulmonary diseases and clinical allergology and to provide high-quality training for medical doctors during their specialization in pulmonary diseases and clinical allergology.